NASDAQ
Dermata Therapeutics, Inc. (DRMA) has a free cash flow growth of -86.56% as of Friday, May 29, 2026. This represents a 743.82% decrease compared to its 12-month average of 13.44%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.